Patent Assignment
Reel/Frame 075871/0801
Change of Name
Recorded: 2026-06-15
Pages: 3
Assignor
CIT THERAPEUTICS LLC
Executed: 2025-05-06
Assignee
CIT THERAPEUTICS, INC.
2625 RIDGEGATE ROW, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine Sumo Inhibitors and Uses Thereof
Application:
17/793,191 →
Publication:
US US20230303584A1
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 17, 2022
From: OUYANG, XIAOHU; KUBOTA, MILES DOUGLAS; TASKER, ANDREW STEWART
To: SUMO BIOSCIENCES INC.
Reel/Frame 061438/0235 →
Assignment of Assignor's Interest
Oct 17, 2022
From: OUYANG, XIAOHU; KUBOTA, MILES DOUGLAS; TASKER, ANDREW STEWART; HONG, FANG-TSAO
To: ONCOVALENT THERAPEUTICS INC.
Reel/Frame 061438/0485 →
Change of Name
Oct 17, 2022
From: SUMO BIOSCIENCES INC.
To: ONCOVALENT THERAPEUTICS INC.
Reel/Frame 061689/0836 →
Assignment of Assignor's Interest
Sep 14, 2023
From: ONCOVALENT THERAPEUTICS INC.
To: SUVALENT THERAPEUTICS INC.
Reel/Frame 064899/0307 →
Assignment of Assignor's Interest
Dec 23, 2025
From: SUVALENT THERAPEUTICS, INC.
To: CIT THERAPEUTICS LLC
Reel/Frame 073303/0442 →